CHPA released the following statement today by President and CEO, Scott Melville, applauding the introduction of The Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018
We applaud FDA for focusing their enforcement efforts on homeopathic drug products that do not meet manufacturing standards, contain harmful ingredients, or are OTC products with prescription indications.
The 2017 results from the National Institute on Drug Abuse and University of Michigan’s annual drug abuse survey were released today showing that the percentage of teens using OTC cough medicine containing DXM to get high remains at just three percent, the lowest level recorded since 2015.
CHPA applauds Representative Lynn Jenkins on her recent introduction of H.R. 4618 which will provide two years of tax relief for millions of consumers by allowing them, once again, to use their existing HSAs and FSAs to purchase OTC medicines.
Today, CHPA announced a new initiative to support retailers in states that have adopted laws prohibiting the sale of OTC medicines containing the cough suppressant dextromethorphan to minors. The announcement comes on the heels of Nevada’s enactment of a DXM age-restriction law last week.
CHPA applauds AHPA’s new guidelines on Good Agricultural and Collection Practices and Good Manufacturing Practices for Botanical Material, and acknowledges their importance in helping to ensure the production and supply of high-quality herbal raw materials.
On behalf of the CHPA Dietary Supplements Committee, we are writing to express our concern with the recent decision by the Joint Committee to include certain elements of 21 CFR 117 within the consensus-based standard for dietary supplements.
We are supportive of the International Pharmaceutical Excipient Council of The Americas' recommendations detailed in their correspondence that USP remove references to dietary supplements and their ingredients.
Letter regarding modernization of the USP compendia for OTC medicines. CHPA supports improving the compendial test methods and establishing product standards for safety.
To combat teen abuse of over-the-counter (OTC) medicines containing the cough suppressant dextromethorphan (DXM), Oregon Governor Kate Brown today signed legislation prohibiting the sale of DXM-containing products to minors.
